Dhruv Bansal, MD, MBA

Alumni

Began fellowship in 2019

Graduated in 2021

Initial post-graduate position:

Private Practice, St. Luke's Hospital, Kansas City, MO

Biosketch

Education
2000-2006	MD, Smt. NHL Municipal Medical College, Ahmedabad, India
2016-2018	MBA, Washington University, St. Louis, MO
Post-graduate Training
2008-2011	Residency, Internal Medicine, University of New Mexico, Albuquerque, NM
2018-2019	Fellowship, Hematology & Oncology, Loma Linda University, Loma Linda, CA
Employment
2011-2014	Primary Care Physician, Hospitalist, Hospice Director, Pharmacy Director, St. Anthony Health Center, St. Louis, MO
2014-2018	Bone Marrow Transplant Hospitalist, Barnes Jewish-Hospital, St. Louis, MO
Awards
2016	Platinum Chapter Award, Society of Hospital Medicine
2017	Distinguished Faculty Award, Washington University School of Medicine

Immunotherapy and Immunotherapy Combinations in Metastatic Castration-Resistant Prostate Cancer
Bansal D, Reimers MA, Knoche EM, Pachynski RK
Cancers (Basel) 2021 Jan 18;13(2)
Lenalidomide Results in a Durable Complete Remission in Acute Myeloid Leukemia Accompanied by Persistence of Somatic Mutations and a T-Cell Infiltrate in the Bone Marrow
Bansal D, Vij K, Chang GS, Miller CA, DiPersio JF, Vij R, Heath SE, Westervelt P, Welch JS, Fehniger TA
Haematologica 2018 Jun;103(6):e270-e273
Proteasome Inhibitor Associated Thrombotic Microangiopathy
Yui JC, Van Keer J, Weiss BM, Waxman AJ, Palmer MB, D'Agati VD, Kastritis E, Dimopoulos MA, Vij R, Bansal D, Dingli D, Nasr SH, Leung N
Am J Hematol 2016 Sep;91(9):E348-52

Myelodysplastic Syndromes
Bansal D, Bansal P
Decision Support in Medicine: Hospital Medicine: 2nd edition. 2019 (https://www.clinicaladvisor.com/home/decision-support-in-medicine/hospital-medicine/myelodysplastic-syndromes/)
Chronic Myeloid Leukemia
Bansal D, Bansal P
Decision Support in Medicine: Hospital Medicine: 2nd edition. 2019 (https://www.clinicaladvisor.com/home/decision-support-in-medicine/hospital-medicine/chronic-myeloid-leukemia/)